TERMINATED CONTRACT FOR FDA LICENSURE OF A BIOSCAVENGER PROPHYLAXIS.
Award details are derived from public USAspending.gov records. Not a bid recommendation.
Award details
- Award ID
- W911QY13C0056
- Contractor
- DYNPORT VACCINE COMPANY LLC
- Awarding agency
- Department of Defense
- Sub-agency / office
- Department of the Army
- Award amount
- $257,417,661
- Period of performance
- May 9, 2013 – May 22, 2023
- NAICS
- 541711 — Research and Development in Biotechnology
- PSC
- PSC 6505
- Place of performance
- FREDERICK, MD, 217024501, USA
- Competition
- FULL AND OPEN COMPETITION · Set-aside: NO SET ASIDE USED. · 1 offers
- Pricing
- COST PLUS FIXED FEE
- Financial breakdown
- Current value $257,417,661 · Obligated $117,632,941 · Potential value $258,064,432 · Latest action obligation $-316,912 · Outlays $0
Public award description
TERMINATED CONTRACT FOR FDA LICENSURE OF A BIOSCAVENGER PROPHYLAXIS.
Related intelligence
Related Federal Awards
- · W81XWH20F0253 — COVID-19-FDA EUA ANTIGEN DETECTION- FDA FAST TRACK SEROLOGY ASSAY OPTIMIZATION · INBIOS INTERNATIONAL INC · Department of Defense · $25,655,995
- · W81XWH15C0048 — THIS REQUIREMENT IS FOR COMMERCIALIZATION OF FREEZE DRIED PLASMA PRODUCT. · WESTAT, INC. · Department of Defense · $23,174,896
- · HR001115C0125 — IGF::OT::IGF - DEKA INTEGRATED SOLUTIONS CORP. PROSTHETIC ARMS AND SUPPORT FOR THE HAPTIX PROGRAM AND REVOL… · DEKA INTEGRATED SOLUTIONS CORP · Department of Defense · $8,904,988
- · 75N93021F00006 — PRE-CLINICAL MODELS OF INFECTIOUS DISEASES · Department of Health and Human Services · $685,892
- · 75N94021F00008 — NIAAA - ONE-YEAR STANDING ORDER FOR GENOTYPING SERVICES · TRANSNETYX, INC · Department of Health and Human Services · $25,000
- · HHSN27200003 — IGF::OT::IGF 1500005I DYNPORT VACCINE COMPANY, LLC; TO 15-0109.B1.0052--05 BASE; BIOD CAN 8470038; $59,564 · Department of Health and Human Services